In my opinion, on can assume a steady 15 pc kind of bottomline growth every year with scope for positive surprises baked in. No one knows which molecule is gonna go commercial at which time and its revenue potential
However, in serious CDMO businesses like Neuland … one can expect unexpected upsides even if 1-2 molecules end up becoming hit/blockbuster in the developed Mkts
Disc: holding, biased
| Subscribe To Our Free Newsletter |
